Recombinant multi-species CPSF6 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CPSF6 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is one subunit of a cleavage factor required for 3' RNA cleavage and polyadenylation processing. The interaction of the protein with the RNA is one of the earliest steps in the assembly of the 3' end processing complex and facilitates the recruitment of other processing factors. The cleavage factor complex is composed of four polypeptides. This gene encodes the 68kD subunit. It has a domain organization reminiscent of spliceosomal proteins. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 4733401N12Rik,CFIM,CFIM68,CFIM72,CPSF6,Cleavage and polyadenylation specificity factor 68 kDa subunit (CPSF 68 kDa subunit),Cleavage and polyadenylation specificity factor subunit 6,Cleavage factor Im complex 68 kDa subunit (CFIm68),Cpsf6,HPBRII-4,HPBRII-7,Pre-mRNA cleavage factor Im 68 kDa subunit,Protein HPBRII-4/7

Target products collectionGo to CPSF6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP3921-Ag-1/ GM-Tg-hg-IP3921-Ag-2 Human CPSF6 protein Human
GM-Tg-rg-IP3921-Ag-1/ GM-Tg-rg-IP3921-Ag-2 Rat CPSF6 protein Rat
GM-Tg-mg-IP3921-Ag-1/ GM-Tg-mg-IP3921-Ag-2 Mouse CPSF6 protein Mouse
GM-Tg-cynog-IP3921-Ag-1/ GM-Tg-cynog-IP3921-Ag-2 Cynomolgus/Rhesus macaque CPSF6 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP3921-Ag-1/ GM-Tg-felg-IP3921-Ag-2 Feline CPSF6 protein Feline
GM-Tg-cang-IP3921-Ag-1/ GM-Tg-cang-IP3921-Ag-2 Canine CPSF6 protein Canine
GM-Tg-bovg-IP3921-Ag-1/ GM-Tg-bovg-IP3921-Ag-2 Bovine CPSF6 protein Bovine
GM-Tg-equg-IP3921-Ag-1/ GM-Tg-equg-IP3921-Ag-2 Equine CPSF6 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP3921-Ag-1/ GM-Tg-hg-IP3921-Ag-2; GM-Tg-rg-IP3921-Ag-1/ GM-Tg-rg-IP3921-Ag-2;
GM-Tg-mg-IP3921-Ag-1/ GM-Tg-mg-IP3921-Ag-2; GM-Tg-cynog-IP3921-Ag-1/ GM-Tg-cynog-IP3921-Ag-2;
GM-Tg-felg-IP3921-Ag-1/ GM-Tg-felg-IP3921-Ag-2; GM-Tg-cang-IP3921-Ag-1/ GM-Tg-cang-IP3921-Ag-2;
GM-Tg-bovg-IP3921-Ag-1/ GM-Tg-bovg-IP3921-Ag-2; GM-Tg-equg-IP3921-Ag-1/ GM-Tg-equg-IP3921-Ag-2
Products Name CPSF6 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CPSF6
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CPSF6 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.